Related Articles
Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis
Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?
FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics
HER2 analysis in breast cancer: Reduced immunoreactivity in FISH non-informative cancer biopsies
Modified direct-double-differential PCR for gene dosage quantification of HER2